Illumina (ILMN.US) — market event timeline

nashnova tracks 1 market event mentioning Illumina (ILMN.US) as of 2026-09-24, each with a dated one-line analysis of how the event relates to the asset.

  1. GRAIL's Multi-Cancer Early Detection Blood Test Galleri Receives FDA Advisory Committee Endorsement

    Galleri testing relies on Illumina's sequencing platform; former parent company of GRAIL and core upstream supplier.

For research and information only — not investment advice.

Illumina (ILMN.US) — News & AI Analysis · nashnova